Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera cash
Cash and short-term investments held at the end of each period.
Biofrontera's cash was $4.66M at Jun 30, 2026. For fiscal 2025 it was $6.39M, up 8.2% from the year before. The highest annual figure on record is $24.55M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.39M | +8.2% |
| FY2024 | Dec 31, 2024 | $5.91M | +339.7% |
| FY2023 | Dec 31, 2023 | $1.34M | -92.2% |
| FY2022 | Dec 31, 2022 | $17.21M | -29.9% |
| FY2021 | Dec 31, 2021 | $24.55M | +203.8% |
| FY2020 | Dec 31, 2020 | $8.08M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.66M | -35.6% |
| Q1 FY2026 | Mar 31, 2026 | $6.32M | +253.9% |
| Q4 FY2025 | Dec 31, 2025 | $6.39M | +8.2% |
| Q3 FY2025 | Sep 30, 2025 | $3.42M | +18.9% |
| Q2 FY2025 | Jun 30, 2025 | $7.24M | +65.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.79M | -53.2% |
| Q4 FY2024 | Dec 31, 2024 | $5.91M | +339.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.87M | -16.0% |
| Q2 FY2024 | Jun 30, 2024 | $4.38M | -1.7% |
| Q1 FY2024 | Mar 31, 2024 | $3.82M | +193.6% |
| Q4 FY2023 | Dec 31, 2023 | $1.34M | -92.2% |
| Q3 FY2023 | Sep 30, 2023 | $3.42M | -87.6% |
| Q2 FY2023 | Jun 30, 2023 | $4.45M | -86.0% |
| Q1 FY2023 | Mar 31, 2023 | $1.30M | -94.2% |
| Q4 FY2022 | Dec 31, 2022 | $17.21M | -29.9% |
| Q3 FY2022 | Sep 30, 2022 | $27.52M | +1503.6% |
| Q2 FY2022 | Jun 30, 2022 | $31.91M | +295.0% |
| Q1 FY2022 | Mar 31, 2022 | $22.43M | – |
| Q4 FY2021 | Dec 31, 2021 | $24.55M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.72M | – |
| Q4 FY2020 | Dec 31, 2020 | $8.08M | – |